Alcántara-Montiel JC, Vega-Torres BI. Hyper-IgE syndrome.
Lessons from function and defects of STAT-3 or DOCK-8. Rev
Alerg Mex. 2016;63(4):385–396....
Kao AS, Deirawan H, Poowuttikul P, Daveluy S. Hyper IgE
syndrome-related disease treated with dupilumab: a case
report. Clin Case Rep. 2023;11(9):e7614....
Charvet E, Bourrat E, Hickman G, et al. Efficacy of dupilumab
for controlling severe atopic dermatitis with dominantnegative CARD11 variant....
Lévy R, Béziat V, Barbieux C, et al. Efficacy of dupilumab for
controlling severe atopic dermatitis in a patient with hyperIgE syndrome. J...
Wang H-J, T–T Yang, C-CE Lan. Dupilumab treatment of
eczema in a child with STAT3 hyper-immunoglobulin E
syndrome. J Eur Acad Dermatol Venereol....
Matucci-Cerinic C, Viglizzo G, Pastorino C, et al. Remission of
eczema and recovery of Th1 polarization following treatment
with dupilumab...
Lu C-W, Lee W-I, Chung W-H. Dupilumab for STAT3-hyper-IgE
syndrome with refractory intestinal complication. Pediatrics.
2021;148(3). doi:10.1542/peds.2021-050351.
Sogkas G, Hirsch S, Jablonka A, Witte T, Schmidt RE,
Atschekzei F. Dupilumab to treat severe atopic dermatitis in
autosomal dominant hyper-IgE...
Nihal A, Comstock JR, Holland KE, Singh AM, Seroogy CM,
Arkin LM. Clearance of atypical cutaneous manifestations of
hyper-IgE syndrome with...
Staudacher O, Krüger R, Kölsch U, et al. Relieving job:
dupilumab in autosomal dominant STAT3 hyper-IgE syndrome. J Allergy Clin Immunol Pract....
Dixit C, Thatayatikom A, Pappa H, Knutsen AP. Treatment of
severe atopic dermatitis and eosinophilic esophagitis with
dupilumab in a 14-year-old...
Ollech A, Mashiah J, Lev A, et al. Treatment options for DOCK8
deficiency-related severe dermatitis. J Dermatol. 2021;48(9):
1386–1393. doi:10.1111/1346-8138.15955.
García-García A, Buendia Arellano M, Deyà-Martínez À, et al.
Novel PGM3 compound heterozygous variants with IgE-
related dermatitis, lymphopenia,...
Zhang Y, Yu X, Ichikawa M, et al. Autosomal recessive
phosphoglucomutase 3 (PGM3) mutations link glycosylation
defects to atopy, immune deficiency,...
Ferreira S, Torres T. El dupilumab para el tratamiento de la
dermatitis atópica. Pediatr Dermatol. 2021;38(6):e43–e44. doi:10.
1111/pde.14873.
Eichenfield LF, Bieber T, Beck LA, et al. Infections in
dupilumab clinical trials in stopic dermatitis: a comprehensive pooled analysis. Am...
Ong P, Cork MJ, Armstrong A. 34,326 real-world analysis of
skin infections and antimicrobial use among patients with
atopic dermatitis before...
